HLS Therapeutics Inc. (HLTRF)
OTCMKTS · Delayed Price · Currency is USD
3.660
0.00 (0.00%)
At close: Jun 4, 2025

HLS Therapeutics Statistics

Total Valuation

HLTRF has a market cap or net worth of 113.71 million. The enterprise value is 162.02 million.

Market Cap 113.71M
Enterprise Value 162.02M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 31.63M
Shares Outstanding n/a
Shares Change (YoY) -1.10%
Shares Change (QoQ) +5.17%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 19.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.00
PB Ratio 1.70
P/TBV Ratio n/a
P/FCF Ratio 10.59
P/OCF Ratio 10.56
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.80, with an EV/FCF ratio of 15.09.

EV / Earnings -9.01
EV / Sales 2.72
EV / EBITDA 9.80
EV / EBIT n/a
EV / FCF 15.09

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.95.

Current Ratio 1.43
Quick Ratio 1.07
Debt / Equity 0.95
Debt / EBITDA 4.05
Debt / FCF 5.94
Interest Coverage -0.68

Financial Efficiency

Return on equity (ROE) is -23.08% and return on invested capital (ROIC) is -2.63%.

Return on Equity (ROE) -23.08%
Return on Assets (ROA) -2.28%
Return on Invested Capital (ROIC) -2.63%
Return on Capital Employed (ROCE) -4.93%
Revenue Per Employee 617,054
Profits Per Employee -195,489
Employee Count 92
Asset Turnover 0.32
Inventory Turnover 1.76

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +26.21% in the last 52 weeks. The beta is 1.03, so HLTRF's price volatility has been similar to the market average.

Beta (5Y) 1.03
52-Week Price Change +26.21%
50-Day Moving Average 2.76
200-Day Moving Average 5.67
Relative Strength Index (RSI) 64.13
Average Volume (20 Days) 924

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HLTRF had revenue of 56.77 million and -17.99 million in losses. Loss per share was -0.57.

Revenue 56.77M
Gross Profit 41.31M
Operating Income -6.41M
Pretax Income -13.91M
Net Income -17.99M
EBITDA 15.70M
EBIT -6.41M
Loss Per Share -0.57
Full Income Statement

Balance Sheet

The company has 17.73 million in cash and 63.74 million in debt, giving a net cash position of -46.01 million.

Cash & Cash Equivalents 17.73M
Total Debt 63.74M
Net Cash -46.01M
Net Cash Per Share n/a
Equity (Book Value) 66.80M
Book Value Per Share 2.10
Working Capital 10.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.77 million and capital expenditures -34,000, giving a free cash flow of 10.73 million.

Operating Cash Flow 10.77M
Capital Expenditures -34,000
Free Cash Flow 10.73M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 72.78%, with operating and profit margins of -11.29% and -31.68%.

Gross Margin 72.78%
Operating Margin -11.29%
Pretax Margin -24.50%
Profit Margin -31.68%
EBITDA Margin 27.66%
EBIT Margin -11.29%
FCF Margin 18.91%

Dividends & Yields

HLTRF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.10%
Shareholder Yield n/a
Earnings Yield -15.82%
FCF Yield 9.44%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HLTRF has an Altman Z-Score of -0.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.9
Piotroski F-Score n/a